Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MoonLake Immunotherapeutics - Class A Ordinary Shares
(NQ:
MLTX
)
13.64
-0.19 (-1.37%)
Streaming Delayed Price
Updated: 10:19 AM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about MoonLake Immunotherapeutics - Class A Ordinary Shares
< Previous
1
2
3
4
5
6
Next >
Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash
↗
November 28, 2025
A brutal 90% single-day crash and a shareholder’s full exit raise the stakes for MoonLake’s upcoming FDA meeting.
Via
The Motley Fool
Topics
Lawsuit
Regulatory Compliance
Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash
↗
November 27, 2025
A brutal 90% single-day crash and a shareholder’s full exit raise the stakes for MoonLake’s upcoming FDA meeting.
Via
The Motley Fool
Topics
Lawsuit
Regulatory Compliance
5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out
↗
November 18, 2025
A major biotech investor just walked away from MoonLake after a rough year for the stock. Here’s what that move signals—and what long-term investors should keep an eye on next.
Via
The Motley Fool
MoonLake Therapeutics Stock Sparks Retail Frenzy Ahead Of New York Summit — Traders See 'Nonstop Catalysts' Through 2026
↗
November 13, 2025
Via
Stocktwits
MoonLake Stock Climbs After-Hours: Retail Traders Shrug Off Record Plunge, More Wall Street Downgrades
↗
September 29, 2025
Via
Stocktwits
MoonLake Immunotherapeutics Stock Draws Buzz After Skin Drug’s Phase 3 Trial Data — Retail Speculates Buyout, Bigger Gains
↗
September 28, 2025
Via
Stocktwits
The Best AI for Picking Stocks, Ranked by Performance
↗
October 22, 2025
AI can pick stocks, but that doesn't mean it will do a good job. Here's a look at how the choices made by 7 leading AIs performed over a 90-day time period.
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Which stocks have an unusual volume on Monday?
↗
October 06, 2025
Volume analysis on 2025-10-06: stocks with an unusual volume in today's session.
Via
Chartmill
Top 3 Health Care Stocks That Are Preparing To Pump In Q4
↗
October 06, 2025
Via
Benzinga
Unusual volume stocks are being observed in Friday's session.
↗
October 03, 2025
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Via
Chartmill
Unusual volume stocks are being observed in Thursday's session.
↗
October 02, 2025
In today's session, these stocks are experiencing unusual volume.
Via
Chartmill
Unusual volume stocks are being observed in Wednesday's session.
↗
October 01, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via
Chartmill
MoonLake Immunotherapeutics Stock Draws Wall Street Attention Post Monday’s Plunge: Retail Sees Significant Upside
↗
September 30, 2025
Needham analyst Serge Belanger lowered the firm's price target on the stock to $20 from $66 but kept a ‘Buy’ rating on the shares.
Via
Stocktwits
Wall Street Lights Up as Cannabis Stocks Blaze Higher, Biotech Melts Down
↗
September 30, 2025
U.S. markets kicked off the week quietly, but certain stocks were anything but dull. Cannabis names surged after a Trump-endorsed CBD video went viral, while biotech firm MoonLake was crushed by...
Via
Chartmill
Topics
Cannabis
Wolfspeed, Tilray, Robinhood, Etsy, And Moonlake Immunotherapeutics: Why These 5 Stocks Are On Investors' Radars Today
↗
September 29, 2025
U.S. stocks advanced today, with the Nasdaq climbing about 107 points, or 0.48%, to 22,591.15. The S&P 500 added 0.26% to close at 6,661.21, while the Dow Jones Industrial Average edged up 0.15% to...
Via
Benzinga
Topics
Stocks
Crude Oil Falls Sharply; Carnival Posts Upbeat Earnings
↗
September 29, 2025
U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Monday. The Dow traded down 0.12% to 46,190.92 while the NASDAQ rose 0.40% to 22,574.89. The S&P 500...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 29, 2025
Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands at $5.5 million. Zura Bio (NASDAQ: ZURA) stock moved upwards by 42.94% to $3.44....
Via
Benzinga
Nasdaq Jumps 150 Points; US Pending Home Sales Rise
↗
September 29, 2025
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. Following the market opening Monday, the Dow traded up 0.19% to 46,333.68 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
MoonLake Crashes 89% On Mixed Results For Skin Disease Treatment
↗
September 29, 2025
MoonLake Immunotherapeutics stock crashed Monday after the company posted mixed results for its skin disease drug.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
September 29, 2025
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.
Via
Benzinga
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
September 29, 2025
U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday. Shares of Inventiva ADR (NASDAQ: IVA) fell sharply in today's pre-market trading following H1...
Via
Benzinga
Topics
Stocks
This Electronic Arts Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
↗
September 29, 2025
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings...
Via
Benzinga
Why Is MoonLake Immunotherapeutics Stock Crashing Premarket?
↗
September 29, 2025
RBC Capital downgraded the stock, calling the results a “near-miss” statistically and warning that the drug’s effect size looked uncompetitive.
Via
Stocktwits
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
↗
September 29, 2025
Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its...
Via
Benzinga
2 Small-Cap Biotech Stocks Well Positioned for a Breakout
↗
August 27, 2025
Clinical trial results expected in the weeks ahead could push shares of these small-cap drugmakers through the roof.
Via
The Motley Fool
Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery
↗
June 13, 2025
Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE-689 trial.
Via
Benzinga
Deal Dispatch: TV Stations For Sale, This Buyer Wants Seconds On Pasta
↗
June 06, 2025
Byron Allen dials out, Salesforce logs in. Here are the various deal announcements of the past week plus bankruptcy updates.
Via
Benzinga
Topics
Bankruptcy
Signet Posts Upbeat Earnings, Joins Ferguson Enterprises, Dollar General And Other Big Stocks Moving Higher On Tuesday
↗
June 03, 2025
Via
Benzinga
Tuesday's session: gap up and gap down stocks
↗
June 03, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Via
Chartmill
MoonLake Immunotherapeutics Catapults On Rumored Merck Takeover
↗
June 03, 2025
The deal is being discussed ahead of key data from MoonLake in patients with a skin disease.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
